SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Tularik Inc. (TLRK) -- Ignore unavailable to you. Want to Upgrade?

To: mike head who wrote (1)10/20/1999 3:59:00 PM
From: dalroi  Read Replies (1) | Respond to of 598
 
nice tularik homepage
BUT WHERE THE *** DO I GET SOME sHARES

tularik.com
bio.org
northernlight.com

pipe seems indeed very promissing
full of patent protection
should have known it if rick was interested



To: mike head who wrote (1)10/20/1999 10:49:00 PM
From: tommysdad  Read Replies (1) | Respond to of 598
 
Respectfully, I would submit that the most relevant competition in the area of nuclear orphans is Glaxo-Wellcome. They're quieter but casting a broader net. Do a literature search on "Willson, Timothy" to start with. Lots of stuff, a lot closer to the clinic.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News